Moscow. Russian President Vladimir Putin announced on Wednesday that he has registered the second Covid-19 vaccine. This information was given in media reports on Wednesday. Russia became the first country to grant regulatory approval to a Covid-19 vaccine in August when the Sputnik-5 vaccine was officially registered. However, some of the scientific community had also criticized it as a hasty vaccine.
The second Russian vaccine vector has been developed on behalf of the State Research Centre of Virology and Biotechnology to obtain regulatory approval. The vector vaccine has been named ‘Apovacoona’, a peptide-based vaccine. According to the Sputnik News Agency report, Putin pointed out that the third Russian vaccine against Covid-19 developed by the Chumkov Centre will also be registered in the near future. The report says that Russian Deputy Prime Minister Tatyana Golicova said that she herself has undergone a trial of the ‘ Apovacokkoona ‘ vaccine and has not experienced any side effects.
An official from the U.S. administration, who is leading efforts to control corona infections in the U.S., has said that the coronavirus vaccine may be available in the country at the beginning of January 2021, while President Donald Trump had said vaccination could start from this month. Several MPs, experts, and public health officials from both the parties say the country is not ready to deal with it in view of the possibility of increasing winter infections.
Dr. Robert Cadlake, assistant minister for preparedness and response at the Department of Health and Human Services (HHS), said in an email on Friday that the administration is accelerating “production of safe and effective vaccines” to ensure their availability at the beginning of January 2021. ”
HHS says the vaccine may be approved before the end of the year, but its distribution will take time. Trump has said in rallies, debates, and press conferences that the vaccine may reach in a few weeks. “We think we can start it at any time in October,” Trump said at a press conference last week. ”